Header Logo

Connection

Mehmet Kocak to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Mehmet Kocak has written about Antibodies, Monoclonal, Humanized.
Mehmet Kocak
Connection Strength
0.193
Antibodies, Monoclonal, Humanized
  1. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls. Rheumatol Int. 2022 03; 42(3):457-467.
    View in: PubMed
    Score: 0.193
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.